• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

混合谱系激酶3将活性氧与京尼平处理的PC3人前列腺癌细胞中c-Jun氨基末端激酶诱导的线粒体凋亡联系起来。

Mixed lineage kinase 3 connects reactive oxygen species to c-Jun NH2-terminal kinase-induced mitochondrial apoptosis in genipin-treated PC3 human prostate cancer cells.

作者信息

Hong Hye-Young, Kim Byung-Chul

机构信息

Division of Life Sciences, Kangwon National University, Chuncheon 200-701, Republic of Korea.

出版信息

Biochem Biophys Res Commun. 2007 Oct 19;362(2):307-12. doi: 10.1016/j.bbrc.2007.07.165. Epub 2007 Aug 9.

DOI:10.1016/j.bbrc.2007.07.165
PMID:17707342
Abstract

It has been reported that genipin, the aglycone of geniposide, induces apoptotic cell death in human hepatoma cells via a NADPH oxidase-reactive oxygen species (ROS)-c-Jun NH(2)-terminal kinase (JNK)-dependent activation of mitochondrial pathway. This continuing work aimed to define that mixed lineage kinase 3 (MLK3) is a key mediator, which connect between ROS and JNK in genipin-induced cell death signaling. In PC3 human prostate cancer cells, genipin stimulated MLK3 activity in concentration- and time-dependent manner. The PC3 cells stably transfected with dominant-negative form of MLK3 was less susceptible to population of the sub-G1 apoptotic cells, activation of caspase, collapse of mitochondrial membrane potential, and release of cytochrome c triggered by genipin, suggesting a crucial role of MLK3 in genipin signaling to apoptotic cell death. Diphenyleneiodonium (DPI), a specific inhibitor of NADPH oxidase, markedly inhibited ROS generation and MLK3 phosphorylation in the genipin-treated cells. Pretreatment with SP0600125, a specific inhibitor of JNK but neither U0126, a specific inhibitor of MEK1/2 nor PD169316, a specific inhibitor of p38 suppressed genipin-induced apoptotic cell death. Notably, both the phosphorylation of JNK and induction of c-Jun induced by genipin were markedly inhibited in PC3-EGFP-MLK3 (K144R) cells expressing a dominant-negative MLK3 mutant. Taken together, our observations suggest genipin signaling to apoptosis of PC3 cells is mediated via activation of ROS-dependent MLK3, which leads to downstream activation of JNK.

摘要

据报道,京尼平苷的苷元京尼平通过烟酰胺腺嘌呤二核苷酸磷酸(NADPH)氧化酶-活性氧(ROS)-c-Jun氨基末端激酶(JNK)依赖性激活线粒体途径,诱导人肝癌细胞发生凋亡性细胞死亡。这项后续研究旨在确定混合谱系激酶3(MLK3)是一个关键介质,它在京尼平诱导的细胞死亡信号传导中连接ROS和JNK。在PC3人前列腺癌细胞中,京尼平以浓度和时间依赖性方式刺激MLK3活性。稳定转染显性负性形式MLK3的PC3细胞对京尼平触发的亚G1期凋亡细胞群体增加、半胱天冬酶激活、线粒体膜电位崩溃和细胞色素c释放的敏感性较低,这表明MLK3在京尼平诱导凋亡性细胞死亡的信号传导中起关键作用。NADPH氧化酶的特异性抑制剂二苯基碘鎓(DPI)显著抑制京尼平处理细胞中的ROS生成和MLK3磷酸化。用JNK特异性抑制剂SP0600125预处理可抑制京尼平诱导的凋亡性细胞死亡,但MEK1/2特异性抑制剂U0126或p38特异性抑制剂PD169316预处理则不能。值得注意的是,在表达显性负性MLK3突变体的PC3-EGFP-MLK3(K144R)细胞中,京尼平诱导的JNK磷酸化和c-Jun诱导均受到显著抑制。综上所述,我们的观察结果表明,京尼平诱导PC3细胞凋亡的信号传导是通过ROS依赖性MLK3的激活介导的,这导致JNK的下游激活。

相似文献

1
Mixed lineage kinase 3 connects reactive oxygen species to c-Jun NH2-terminal kinase-induced mitochondrial apoptosis in genipin-treated PC3 human prostate cancer cells.混合谱系激酶3将活性氧与京尼平处理的PC3人前列腺癌细胞中c-Jun氨基末端激酶诱导的线粒体凋亡联系起来。
Biochem Biophys Res Commun. 2007 Oct 19;362(2):307-12. doi: 10.1016/j.bbrc.2007.07.165. Epub 2007 Aug 9.
2
Genipin-induced apoptosis in hepatoma cells is mediated by reactive oxygen species/c-Jun NH2-terminal kinase-dependent activation of mitochondrial pathway.京尼平诱导肝癌细胞凋亡是由活性氧/c-Jun氨基末端激酶依赖性激活线粒体途径介导的。
Biochem Pharmacol. 2005 Nov 1;70(9):1398-407. doi: 10.1016/j.bcp.2005.07.025.
3
Oxidation-triggered c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein (MAP) kinase pathways for apoptosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis.表没食子儿茶素-3-没食子酸酯(EGCG)刺激下人白血病细胞中氧化触发的c-Jun氨基末端激酶(JNK)和p38丝裂原活化蛋白(MAP)激酶凋亡途径:与化学诱导凋亡和受体介导凋亡不同的途径
Biochem J. 2002 Dec 15;368(Pt 3):705-20. doi: 10.1042/BJ20020101.
4
Genipin induced apoptosis associated with activation of the c-Jun NH2-terminal kinase and p53 protein in HeLa cells.栀子苷诱导 HeLa 细胞凋亡与 c-Jun NH2-末端激酶和 p53 蛋白的激活有关。
Biol Pharm Bull. 2010;33(8):1343-8. doi: 10.1248/bpb.33.1343.
5
ER-Dependent Ca++-mediated Cytosolic ROS as an Effector for Induction of Mitochondrial Apoptotic and ATM-JNK Signal Pathways in Gallic Acid-treated Human Oral Cancer Cells.内质网依赖的钙离子介导的胞质活性氧作为没食子酸处理的人口腔癌细胞中线粒体凋亡和ATM-JNK信号通路诱导的效应分子。
Anticancer Res. 2016 Feb;36(2):697-705.
6
A combination of sulindac and arsenic trioxide synergistically induces apoptosis in human lung cancer H1299 cells via c-Jun NH2-terminal kinase-dependent Bcl-xL phosphorylation.舒林酸和三氧化二砷联合用药通过c-Jun氨基末端激酶依赖性Bcl-xL磷酸化协同诱导人肺癌H1299细胞凋亡。
Lung Cancer. 2008 Sep;61(3):317-27. doi: 10.1016/j.lungcan.2008.01.002. Epub 2008 Feb 20.
7
The hierarchical relationship between MAPK signaling and ROS generation in human leukemia cells undergoing apoptosis in response to the proteasome inhibitor Bortezomib.在响应蛋白酶体抑制剂硼替佐米而发生凋亡的人白血病细胞中,MAPK信号传导与活性氧生成之间的层级关系。
Exp Cell Res. 2004 May 1;295(2):555-66. doi: 10.1016/j.yexcr.2004.02.001.
8
Overcoming the radioresistance of prostate cancer cells with a novel Bcl-2 inhibitor.用一种新型Bcl-2抑制剂克服前列腺癌细胞的放射抗性。
Oncogene. 2007 Feb 1;26(5):652-61. doi: 10.1038/sj.onc.1209830. Epub 2006 Aug 7.
9
Surfactin induces apoptosis in human breast cancer MCF-7 cells through a ROS/JNK-mediated mitochondrial/caspase pathway.表面活性剂通过 ROS/JNK 介导的线粒体/半胱天冬酶途径诱导人乳腺癌 MCF-7 细胞凋亡。
Chem Biol Interact. 2010 Feb 12;183(3):357-62. doi: 10.1016/j.cbi.2009.11.027. Epub 2009 Nov 30.
10
Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N-terminal kinase pathways in human melanoma A375.S2 cells.白花丹醌通过活性氧/c-Jun氨基末端激酶途径诱导人黑色素瘤A375.S2细胞的细胞周期阻滞和凋亡。
Cancer Lett. 2008 Jan 18;259(1):82-98. doi: 10.1016/j.canlet.2007.10.005. Epub 2007 Nov 19.

引用本文的文献

1
Genipin's potential as an anti-cancer agent: from phytochemical origins to clinical prospects.栀子苷作为抗癌药物的潜力:从植物化学起源到临床前景。
Med Oncol. 2024 Jun 25;41(8):186. doi: 10.1007/s12032-024-02429-y.
2
Genipin, an Inhibitor of UCP2 as a Promising New Anticancer Agent: A Review of the Literature.栀子苷作为 UCP2 抑制剂:一种有前景的新型抗癌药物——文献综述。
Int J Mol Sci. 2022 May 18;23(10):5637. doi: 10.3390/ijms23105637.
3
Unravelling the Role of Kinases That Underpin Androgen Signalling in Prostate Cancer.揭示激酶在前列腺癌中支撑雄激素信号的作用。
Cells. 2022 Mar 10;11(6):952. doi: 10.3390/cells11060952.
4
Three-Dimensional Printability of an ECM-Based Gelatin Methacryloyl (GelMA) Biomaterial for Potential Neuroregeneration.一种基于细胞外基质的甲基丙烯酰化明胶(GelMA)生物材料用于潜在神经再生的三维可打印性
ACS Omega. 2021 Jul 19;6(33):21368-21383. doi: 10.1021/acsomega.1c01903. eCollection 2021 Aug 24.
5
The regulatory function of mixed lineage kinase 3 in tumor and host immunity.混合谱系激酶 3 在肿瘤和宿主免疫中的调节功能。
Pharmacol Ther. 2021 Mar;219:107704. doi: 10.1016/j.pharmthera.2020.107704. Epub 2020 Oct 9.
6
Molecular Mechanisms Responsible for Pharmacological Effects of Genipin on Mitochondrial Proteins.栀子苷对线粒体蛋白的药理作用的分子机制。
Biophys J. 2019 Nov 19;117(10):1845-1857. doi: 10.1016/j.bpj.2019.10.021. Epub 2019 Oct 24.
7
Evaluation of the Inhibitory Effects of Genipin on the Fluoxetine-Induced Invasive and Metastatic Model in Human HepG2 Cells.栀子苷对氟西汀诱导的人 HepG2 细胞侵袭转移模型的抑制作用评价。
Molecules. 2018 Dec 14;23(12):3327. doi: 10.3390/molecules23123327.
8
Dexmedetomidine Ameliorates Acute Stress-Induced Kidney Injury by Attenuating Oxidative Stress and Apoptosis through Inhibition of the ROS/JNK Signaling Pathway.右美托咪定通过抑制 ROS/JNK 信号通路减轻氧化应激和细胞凋亡来改善急性应激诱导的肾损伤。
Oxid Med Cell Longev. 2018 Sep 3;2018:4035310. doi: 10.1155/2018/4035310. eCollection 2018.
9
Plant-Derived Anticancer Agents: Lessons from the Pharmacology of Geniposide and Its Aglycone, Genipin.植物源抗癌剂:栀子苷及其苷元京尼平的药理学启示
Biomedicines. 2018 Mar 26;6(2):39. doi: 10.3390/biomedicines6020039.
10
Genipin suppresses colorectal cancer cells by inhibiting the Sonic Hedgehog pathway.京尼平通过抑制音猬因子信号通路来抑制结肠癌细胞。
Oncotarget. 2017 Oct 16;8(60):101952-101964. doi: 10.18632/oncotarget.21882. eCollection 2017 Nov 24.